3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 24 0 1 0 0 0 0 0999 V2000
2.5181 -0.1897 -1.0575 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8663 1.6438 -0.3191 O 0 5 0 0 0 0 0 0 0 0 0 0
-0.8678 2.2365 0.3826 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0384 -0.4244 0.3339 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1455 -2.2469 -0.2284 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.6855 1.3434 0.0189 N 0 3 0 0 0 0 0 0 0 0 0 0
1.0679 0.4192 0.7847 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9399 0.9183 -0.3711 C 0 0 1 0 0 0 0 0 0 0 0 0
0.0068 -1.7736 0.1913 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2787 0.0051 -0.0091 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0837 1.7799 0.1455 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9512 -1.1432 -0.3559 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2170 -2.5684 0.4841 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6833 -0.2067 1.4418 H 0 0 0 0 0 0 0 0 0 0 0 0
0.7097 1.2052 1.4509 H 0 0 0 0 0 0 0 0 0 0 0 0
1.3513 1.4937 -1.0941 H 0 0 0 0 0 0 0 0 0 0 0 0
3.7160 2.1124 -0.6849 H 0 0 0 0 0 0 0 0 0 0 0 0
2.7090 2.6623 0.6731 H 0 0 0 0 0 0 0 0 0 0 0 0
3.7299 1.2118 0.8240 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9744 -1.2383 -0.6909 H 0 0 0 0 0 0 0 0 0 0 0 0
1.9971 -2.4276 -0.2653 H 0 0 0 0 0 0 0 0 0 0 0 0
1.6218 -2.3561 1.4774 H 0 0 0 0 0 0 0 0 0 0 0 0
0.9635 -3.6348 0.4744 H 0 0 0 0 0 0 0 0 0 0 0 0
1.8309 -0.5672 -1.6325 H 0 0 0 0 0 0 0 0 0 0 0 0
1 8 1 0 0 0 0
1 24 1 0 0 0 0
2 6 1 0 0 0 0
3 6 2 0 0 0 0
4 7 1 0 0 0 0
4 9 1 0 0 0 0
4 10 1 0 0 0 0
5 9 2 0 0 0 0
5 12 1 0 0 0 0
6 10 1 0 0 0 0
7 8 1 0 0 0 0
7 14 1 0 0 0 0
7 15 1 0 0 0 0
8 11 1 0 0 0 0
8 16 1 0 0 0 0
9 13 1 0 0 0 0
10 12 2 0 0 0 0
11 17 1 0 0 0 0
11 18 1 0 0 0 0
11 19 1 0 0 0 0
12 20 1 0 0 0 0
13 21 1 0 0 0 0
13 22 1 0 0 0 0
13 23 1 0 0 0 0
M CHG 2 2 -1 6 1
4. 国际命名与标识
4.1 IUPAC Name
1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
4.2 InChl
InChI=1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3
4.3 InChlKey
KPQZUUQMTUIKBP-UHFFFAOYSA-N
4.4 Canonical SMILES
CC1=NC=C(N1CC(C)O)[N+](=O)[O-]
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病